期刊
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
卷 63, 期 4, 页码 722-729出版社
WILEY
DOI: 10.1111/jgs.13349
关键词
blood pressure management; hypertension; ischemic stroke; stroke prevention; lacunar stroke
资金
- National Institute of Neurological Disorders and Stroke [2 U01 NS38529-04A1]
ObjectivesTo determine safety and tolerability of lowering blood pressure in older adults with lacunar stroke. DesignCohort study. SettingThe Secondary Prevention of Small Subcortical Strokes (SPS3) Trial, which compared the efficacy of two systolic blood pressure (SBP) targets (<130mmHg and 130-149mmHg) for secondary stroke prevention. ParticipantsOf 3,020 SPS3 participants, 494 aged 75 and older at baseline were used in these analyses. MeasurementsRates of side effects related to lowering SBP and clinical outcomes, including stroke recurrence and vascular death, were examined. ResultsOlder participants achieved SBP levels similar to those of younger participants (mean SBP of 125mmHg and 137mmHg in lower and higher SBP target groups, respectively). At least once during the approximately 3.5years of follow-up, 21% reported dizziness, and 15% reported lightheadedness when standing; the only significant difference between the younger and older groups was unsteadiness when standing (23% vs 32% respectively, P<.001). There was no difference according to treatment group. In younger adults, recurrent stroke was less likely in the lower than the higher SBP group (hazard ratio (HR)=0.77, 95% confidence interval (CI)=0.59-1.01) but not in older participants (HR=1.01, 95% CI=0.59-1.73), although the interaction was not significant (P=.39). The lower SBP target was associated with a significant reduction in vascular death in older participants (HR=0.42, 95% CI=0.18-0.98), with a significant interaction between age and SBP group (P=.049). ConclusionExcept for unsteadiness when standing, there was no difference according to age in individuals with lacunar stroke with respect to side effects potentially related to lowering blood pressure. Although the lower SBP target was not associated with lower likelihood of recurrent stroke, these exploratory analyses suggested a possible benefit related to vascular death.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据